Due to the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), the conventional treatment used for other breast cancers is not effective in TNBC. The gene discussed is ERBB2; the disease is breast carcinoma.